Wang, M., Liu, Y., Li, T., Zhang, X., Jiang, Y., Zuo, X., & Yuan, X. Efficacy and safety of belimumab versus rituximab for refractory immune thrombocytopenia in patients with connective tissue disease. BMJ Publishing Group.
Chicago Style (17th ed.) CitationWang, Min, Yudong Liu, Tong Li, Xuan Zhang, Ying Jiang, Xiaoxia Zuo, and Xiangning Yuan. Efficacy and Safety of Belimumab Versus Rituximab for Refractory Immune Thrombocytopenia in Patients with Connective Tissue Disease. BMJ Publishing Group.
MLA (9th ed.) CitationWang, Min, et al. Efficacy and Safety of Belimumab Versus Rituximab for Refractory Immune Thrombocytopenia in Patients with Connective Tissue Disease. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.